Iksuda Therapeutics Ltd.
3 clinical trials · Sponsor
◉ Watch Iksuda Therapeutics Ltd.
| Record | Firm | Date |
|---|---|---|
| IKS04 Regimen in Advanced Solid Tumors That Express CA242 (NCT07738939) | Iksuda Therapeutics Ltd. | 2026-11-01 |
| IKS014 in Advanced Solid Tumors That Express HER2 (NCT05872295) | Iksuda Therapeutics Ltd. | 2023-09-14 |
| IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas (NCT05365659) | Iksuda Therapeutics Ltd. | 2023-09-05 |
Track Iksuda Therapeutics Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.